Abstract 921: Novel clinical targets revealed by kinome reprogramming in mutantESR1metastatic breast cancer
Sign Up to like & getrecommendations! Published in 2019 at "Endocrinology"
DOI: 10.1158/1538-7445.am2019-921
Abstract: Background: Approximately half of women with estrogen receptor (ER)-positive breast cancer who undergo adjuvant endocrine therapy (ET) develop disease progression and metastasis. Studies have revealed that up to 40% of metastatic patients develop tumors bearing… read more here.
Keywords: kinome reprogramming; growth; cancer; breast cancer ... See more keywords